GLP-1
US$ 26.70
abbvie glp-1 receptor agonist medications Agonists: A Comprehensive Overview GLP−1 receptor agonists for the
Description
[7] Gregg, E
In the SUSTAIN clinical trial program, cases of pancreatitis were reported, but at rates that did not reach statistical significance in most individual studies when compared to control groups
y.o., years old
Eli Lilly Obesity Pipeline: Key Candidates to Watch Eli Lilly is at the forefront of developing innovative therapies to combat obesity, with several promising GLP-1 therapies in its pipeline
doi: 10.2337/diabetes.52.7.1786 [DOI] [PubMed] [Google Scholar] 121
